Performance comparison of modified ComBat for harmonization of radiomic features for multicenter studies.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
24 06 2020
Historique:
received: 28 01 2020
accepted: 04 05 2020
entrez: 26 6 2020
pubmed: 26 6 2020
medline: 15 12 2020
Statut: epublish

Résumé

Multicenter studies are needed to demonstrate the clinical potential value of radiomics as a prognostic tool. However, variability in scanner models, acquisition protocols and reconstruction settings are unavoidable and radiomic features are notoriously sensitive to these factors, which hinders pooling them in a statistical analysis. A statistical harmonization method called ComBat was developed to deal with the "batch effect" in gene expression microarray data and was used in radiomics studies to deal with the "center-effect". Our goal was to evaluate modifications in ComBat allowing for more flexibility in choosing a reference and improving robustness of the estimation. Two modified ComBat versions were evaluated: M-ComBat allows to transform all features distributions to a chosen reference, instead of the overall mean, providing more flexibility. B-ComBat adds bootstrap and Monte Carlo for improved robustness in the estimation. BM-ComBat combines both modifications. The four versions were compared regarding their ability to harmonize features in a multicenter context in two different clinical datasets. The first contains 119 locally advanced cervical cancer patients from 3 centers, with magnetic resonance imaging and positron emission tomography imaging. In that case ComBat was applied with 3 labels corresponding to each center. The second one contains 98 locally advanced laryngeal cancer patients from 5 centers with contrast-enhanced computed tomography. In that specific case, because imaging settings were highly heterogeneous even within each of the five centers, unsupervised clustering was used to determine two labels for applying ComBat. The impact of each harmonization was evaluated through three different machine learning pipelines for the modelling step in predicting the clinical outcomes, across two performance metrics (balanced accuracy and Matthews correlation coefficient). Before harmonization, almost all radiomic features had significantly different distributions between labels. These differences were successfully removed with all ComBat versions. The predictive ability of the radiomic models was always improved with harmonization and the improved ComBat provided the best results. This was observed consistently in both datasets, through all machine learning pipelines and performance metrics. The proposed modifications allow for more flexibility and robustness in the estimation. They also slightly but consistently improve the predictive power of resulting radiomic models.

Identifiants

pubmed: 32581221
doi: 10.1038/s41598-020-66110-w
pii: 10.1038/s41598-020-66110-w
pmc: PMC7314795
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10248

Références

Eur Radiol. 2018 Sep;28(9):3640-3650
pubmed: 29564594
BMC Bioinformatics. 2015 Feb 25;16:63
pubmed: 25887219
IEEE Trans Med Imaging. 2009 Jun;28(6):881-93
pubmed: 19150782
PLoS One. 2011 Mar 29;6(3):e18202
pubmed: 21479231
Acta Oncol. 2010 Oct;49(7):1012-6
pubmed: 20831489
BMC Bioinformatics. 2006 Feb 23;7:91
pubmed: 16504092
Br J Radiol. 2017 Feb;90(1070):20160665
pubmed: 27936886
Eur J Nucl Med Mol Imaging. 2018 May;45(5):768-786
pubmed: 29222685
Sci Rep. 2019 Mar 18;9(1):4800
pubmed: 30886309
PLoS One. 2016 Jun 07;11(6):e0156594
pubmed: 27272489
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
Radiology. 2016 Feb;278(2):563-77
pubmed: 26579733
J Nucl Med. 2015 Nov;56(11):1667-73
pubmed: 26229145
Radiology. 2019 Apr;291(1):53-59
pubmed: 30694160
Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):864-877
pubmed: 30535746
Radiology. 2020 May;295(2):328-338
pubmed: 32154773
PLoS One. 2011 Feb 28;6(2):e17238
pubmed: 21386892
Med Phys. 2017 Mar;44(3):1050-1062
pubmed: 28112418
EBioMedicine. 2019 Aug;46:160-169
pubmed: 31395503
EBioMedicine. 2019 Sep;47:20-21
pubmed: 31474549
Magn Reson Imaging. 2012 Nov;30(9):1234-48
pubmed: 22898692
Eur J Cancer. 2012 Mar;48(4):441-6
pubmed: 22257792
BMC Med Genomics. 2012 Jun 08;5:23
pubmed: 22682473
Radiother Oncol. 2018 Jun;127(3):370-373
pubmed: 29598835
Radiology. 2019 Aug;292(2):365-373
pubmed: 31210613
Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1344-1361
pubmed: 29500480
BioData Min. 2017 Dec 8;10:35
pubmed: 29234465
J Nucl Med. 2020 Jun;61(6):814-820
pubmed: 31732678
Sci Rep. 2018 Jul 12;8(1):10545
pubmed: 30002441
Pharmacogenomics J. 2010 Aug;10(4):278-91
pubmed: 20676067
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):328-54
pubmed: 25452219
Med Phys. 2018 Jul;45(7):3449-3459
pubmed: 29763967
Nat Rev Clin Oncol. 2017 Dec;14(12):749-762
pubmed: 28975929
J Nucl Med. 2018 Aug;59(8):1321-1328
pubmed: 29301932

Auteurs

R Da-Ano (R)

INSERM, UMR 1101, LaTIM, University of Brest, Brest, France. ronrickarnaiz@gmail.com.

I Masson (I)

INSERM, UMR 1101, LaTIM, University of Brest, Brest, France.
Department of Radiation Oncology, Institut de cancérologie de l'Ouest René-Gauducheau, Saint-Herblain, France.

F Lucia (F)

INSERM, UMR 1101, LaTIM, University of Brest, Brest, France.
Radiation Oncology Department, University Hospital, Brest, France.

M Doré (M)

Department of Radiation Oncology, Institut de cancérologie de l'Ouest René-Gauducheau, Saint-Herblain, France.

P Robin (P)

Department of Nuclear Medicine, University of Brest, Brest, France.

J Alfieri (J)

Department of Radiation Oncology, McGill University Health Centre, Montreal, Quebec, Canada.

C Rousseau (C)

Department of Nuclear Medicine, Institut de cancerologie de l'Ouest René-Gauducheau, Saint-Herblain, France.
CRCINA, University of Nantes, INSERM UMR1232, CNRS-ERL6001, Nantes, France.

A Mervoyer (A)

Department of Radiation Oncology, Institut de cancérologie de l'Ouest René-Gauducheau, Saint-Herblain, France.

C Reinhold (C)

Department of Radiology, McGill University Health Centre, Montreal, Canada.

J Castelli (J)

Radiotherapy Department Cancer, Institute Eugene Marquis, Rennes, France.
University of Rennes 1, LTSI, Rennes, France.

R De Crevoisier (R)

Radiotherapy Department Cancer, Institute Eugene Marquis, Rennes, France.
University of Rennes 1, LTSI, Rennes, France.

J F Rameé (JF)

Department of Medical Oncology, Centre Hospitalier de Vendee, La Roche sur Yon, France.

O Pradier (O)

INSERM, UMR 1101, LaTIM, University of Brest, Brest, France.
Radiation Oncology Department, University Hospital, Brest, France.

U Schick (U)

INSERM, UMR 1101, LaTIM, University of Brest, Brest, France.
Radiation Oncology Department, University Hospital, Brest, France.

D Visvikis (D)

INSERM, UMR 1101, LaTIM, University of Brest, Brest, France.

M Hatt (M)

INSERM, UMR 1101, LaTIM, University of Brest, Brest, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH